Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients
- 1 December 1994
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 39 (12) , 2589-2594
Abstract
Fish oil has been recently proposed as a possible effective treatment in inflammatory bowel disease (IBD); however, a lot of annoying side effects (ie, belching, halitosis, diarrhea, etc) affect patient compliance. We carried out a study of patient tolerance in a group of Crohn's disease (CD) patients with a new fish oil derivative consisting of 500-mg capsules of eicosapentaenoic-docosahexaenoic (EPA 40%-DHA 20%), a free fatty acid mixture (Purepa), and we also evaluated its incorporation into phospholipids, both in plasma and in red cell membranes. Five groups of 10 CD patients in remission received nine Purepa capsules daily in four different preparations (A: uncoated, B: coated, pH 5.5; C: coated, pH 5.5, 60 min time release; D: coated, pH 6.9) and 12 × 1-g capsules daily of a triglyceride preparation (Max-EPA, EPA 18%-DHA 10%), respectively. We coated three of the four Purepa preparations in order to delay the release of contents in an attempt to minimize the side effects. After six weeks of treatment, the group taking Purepa capsules, coated, pH 5.5, 60 min time release (group C) showed the best incorporation of EPA and DHA in red blood cell phospholipid membranes (EPA from 0.2 to 4.4%, DHA from 3.7 to 6.3%), and no side effects were registered, whereas in all other groups side effects were experienced in 50% or more of subjects. This new preparation will make it possible to treat patients for long periods.Keywords
This publication has 28 references indexed in Scilit:
- Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.Gut, 1992
- Fish oil supplementation in pregnancyThe Lancet, 1992
- Treatment of Ulcerative Colitis with Fish Oil n-3-ω-Fatty AcidJournal of Clinical Gastroenterology, 1990
- Therapeutic potential of fish oil in the treatment of ulcerative colitisAlimentary Pharmacology & Therapeutics, 1989
- Cardiovascular Effects of n-3 Fatty AcidsNew England Journal of Medicine, 1988
- Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil FunctionNew England Journal of Medicine, 1985
- Effect of dietary cod-liver oil on the lipid composition of human erythrocyte membranesScandinavian Journal of Clinical and Laboratory Investigation, 1984
- Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjectsAtherosclerosis, 1983
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- The Diet of Canadian Indians and EskimosProceedings of the Nutrition Society, 1953